Fasting C-peptide levels and death resulting from all causes and breast cancer: The health, eating, activity, and lifestyle study

Journal of Clinical Oncology

Volumn 29, Issue 1, 2011, Pages 47-53

  Irwin, Melinda L ^a   Duggan, Catherine ^a   Wang, Ching Yun ^a   Smith, Ashley Wilder ^a   McTiernan, Anne ^a   Baumgartner, Richard N ^a   Baumgartner, Kathy B ^a   Bernstein, Leslie ^a   Ballard Barbash, Rachel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; C PEPTIDE; ESTROGEN RECEPTOR; INSULIN; TAMOXIFEN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; EATING; FEMALE; HAZARD RATIO; HEALTH; HUMAN; INSULIN RELEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR;

BREAST NEOPLASMS; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIFE STYLE; MIDDLE AGED; MOTOR ACTIVITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 79951968328     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.28.4752     Document Type: Article

References (30)

1. Thune I, Ferberg A: Physical activity and cancer risk: Dose-response and cancer, all sites and site specific. Med Science Sports Exerc 33:S530-S550, 2001 (Pubitemid 32524748)
2. Calle EE, Thun MJ: Obesity and cancer. Oncogene 23:6365-6378, 2004 (Pubitemid 39265505)
3. Huang Z, Hankinson SE, Colditz GA, et al: Dual effects of weight and weight gain on breast cancer risk. JAMA 278:1407-1411, 1997 (Pubitemid 27475968)
4. Neilson HK, Friedenreich CM, Brockton NT, et al: Physical activity and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 18:11-27, 2009
5. Kroenke CH, Chen WY, Rosner B, et al: Weight, weight gain and survival after breast cancer diagnosis. J Clin Oncol 23:1370-1378, 2005
6. Chlebowski RT, Aiello E, McTiernan A: Weight loss in breast cancer patient management. J Clin Oncol 20:1128-1143, 2002 (Pubitemid 34141858)
7. Dal Maso L, Zucchetto A, Talamini R, et al: Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 123:2188-2194, 2008
8. Holmes MD, Chen WY, Feskanich D, et al: Physical activity and survival after breast cancer diagnosis. JAMA 293:2479-2486, 2005 (Pubitemid 40705729)
9. Irwin ML, Smith A, McTiernan A, et al: Influence of pre- and post-diagnosis physical activity on mortality in breast cancer survivors: The Health Eating Activity and Lifestyle (HEAL) Study. J Clin Oncol 26:3958-3964, 2008
10. Holick CN, Newcomb PA, Trentham-Dietz A, et al: Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 17:379-386, 2008 (Pubitemid 351272790)
11. Pierce JP, Stefanick ML, Flatt SW, et al: Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 25:2345-2351, 2007 (Pubitemid 46999205)
12. McTiernan A, Ulrich C, Slate S, Potter J: Physical activity and cancer etiology: Associations and mechanisms. Cancer Causes Control 9:487-509, 1998 (Pubitemid 29026912)
13. Irwin ML, McTiernan A, Bernstein L, et al: Relationship of obesity and physical activity with c-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 14:2881-2888, 2005 (Pubitemid 43068820)
14. Irwin ML, Varma K, Alvarez-Reeves, et al: Randomized controlled exercise trial on insulin and IGFs in breast cancer survivors: The Yale Exercise and Survivorship Study. Cancer Epidemiol Biomarkers Prev 18:306-313, 2009
15. Mink PJ, Shahar E, Rosamond W, et al: Serum insulin and glucose levels and breast cancer incidence: The atherosclerosis risk in communities study. Am J Epidemiol 156:349-352, 2002 (Pubitemid 34858003)
16. Michels KB, Solomon CG, Hu FB, et al: Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26:1752-1758, 2003 (Pubitemid 36929115)
17. Del Giudice ME, Fantus IG, Ezzat S, et al: Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47:111-120, 1998 (Pubitemid 28046082)
18. Gunter MJ, Hoover DR, Yu H, et al: Insulin, insulin-like growth factor-I and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 101:48-60, 2009
19. Gunter MJ, Hoover DR, Yu H, et al: A prospective evaluation of insulin and insulin-like growth factor-I as risk factor for endometrial cancer. Cancer Epidemiol Biomarkers Prev 17:921-929, 2008 (Pubitemid 351536424)
20. Gunter MJ, Hoover DR, Yu H, et al: Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 68:329-337, 2008 (Pubitemid 351380136)
21. Goodwin P, Ennis M, Pritchard K, et al: Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J Clin Oncol 20:42-51, 2002 (Pubitemid 34032594)
22. Irwin ML, Crumley D, McTiernan A, et al: Physical activity levels before and after a breast cancer diagnosis: The Health, Eating, Activity, and Lifestyle (HEAL) Study. Cancer 97:1746-1757, 2003
23. Irwin ML, McTiernan A, Bernstein L, et al: Physical activity levels among breast cancer survivors. Med Sci Sports Exerc 36:1484-1491, 2004
24. Irwin ML, McTiernan A, Baumgartner R, et al: Changes in body fat and weight after a breast cancer diagnosis: Influence of demographic, prognostic and lifestyle factors. J Clin Oncol 23:774-782, 2005 (Pubitemid 46224176)
25. McTiernan A, Rajan KB, Tworoger SS, et al: Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 21:1961-1966, 2003
26. Percy C, Stanek E, Gloeckler L: Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 71:242-250, 1981 (Pubitemid 11146407)
27. Kriska A: Modifiable activity questionnaire. Med Sci Sports Exerc 29:S73-S78, 1997
28. Buse JB, Polonsky KS, Burant CF: Type 2 diabetes mellitus, in Kronenberg HM, Melmed S, Polonsky KS, et al: Williams Textbook of Endocrinology (11th ed). Philadelphia, PA, Saunders Elsevier, 2008, pp 363-390
29. Cazzaniga M, Bonanni B, Guerrieri-Gonzaga A, et al: Is it time to test metformin in breast cancer clinical trials? Cancer Epidemiol Biomarkers Prev 18:701-705, 2009
30. Goodwin P, Pritchard K, Ennis M, et al: Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer 8:501-505, 2008